Meletios-Athanasios Dimopoulos

261PUBLICATIONS
501CO-AUTHORS
Medical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersNuclear physicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (261)

|Aug 24, 2026
Myeloma Elderly Prognostic Score (MEPS): A Proposed Prognostic Score Integrating Age, Renal Function, Performance Status, and Ultra-High-Risk Cytogenetics.

|Aug 07, 2026
Validation of the new IMS/IMWG consensus genomic staging (CGS) of high-risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients.

|Jul 28, 2026
Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|May 04, 2026
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

Pageof 44

Frequent Collaborators

118 joint publications

Evangelos Terpos

102 joint publications

Kastritis Efstathios

86 joint publications

Ioannis Ntanasis-Stathopoulos

60 joint publications

Maria Gavriatopoulou